Dipartimento di Ingegneria Elettrica

Contenuti del sito

Menu di navigazione - Torna all'inizio

Contenuto della pagina - Torna all'inizio

Innovative Medicines Initiative 2 (IMI2) - Call 10

Bando IMI2 sostenuto dal partenariato pubblico-privato tra l’Unione Europea (rappresentata dalla Commissione Europea) e l'industria farmaceutica europea (rappresentata dalla Federazione Europea delle Industrie e Associazioni Farmaceutiche, EFPIA).

  • Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials.
  • Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme).
  • Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain).
  • Topic 4: Creation of a pan-European paediatric clinical trials network.
  • Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes.
  • Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs).
  • Topic 7: Patient perspectives in medicines lifecycle.
  • Topic 8: Personalised medicine approaches in autism spectrum disorders.

Per dettagli su topics e criteri di eleggibilità: https://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call10/IMI2_Call10_TopicsText.pdf

Durata suggerita: da 30 mesi a 6 anni, a seconda del topic.

Budget: variabile a seconda del topic.

Action type: Research and Innovation Action (RIA).

Invio della short proposal: attraverso il Horizon 2020 Participant Portal

Deadline: 28 marzo 2017 per short proposal, 14 Settembre 2017 per il progetto completo.

Link: https://www.imi.europa.eu/content/imi-2-call-10